Icon

METHOTREXATE SODIUM (nda008085)- (EQ 2.5MG BASE)

METHOTREXATE SODIUM STRIDES PHARMA
EQ 2.5MG BASE
No No
Expired Expired
None None
None No
Methotrexate Tablets is a dihydrofolate reductase inhibitor indicated for the:  Treatment of adults and pediatric patients with acute lymphoblastic leukemia (ALL) as part of a combination chemotherapy maintenance regimen  Treatment of adults with mycosis fungoides  Treatment of adults with relapsed or refractory non-Hodgkin lymphoma as part of a metronomic combination regimen  Treatment of adults with rheumatoid arthritis  Treatment of pediatric patients with polyarticular juvenile idiopathic arthritis (pJIA)  Treatment of adults with severe psoriasis
12 0 11
Total Other Developers 1
Drugs with Suitability Yes
EQ 2.5MG BASE ** ** - - 10
NDA Sales Available Total Generic Sales Available
No 9
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** ****-**** ******** ***. *********** **** ****** ****, ********, **** (**) *****, ****** ****** (***) ***
****** **** **** ***** ********** *.*.* *********** ********* ***/**, *******, *****, *** **, ***** ******** (***) ***
****** ***** **** ** ***. *********** ** *** ****** **** ********** ****, *** **, ******, ****** **** (**) *****, ****** ****** (***) ***
****** *** ***** ***** ***********, ***** ****** *********** ********** *, *****, **-*****, ******* (***) ***
****** *** ***** ***** ***********, ***** ****** *********** *************** *, *****, **-*****, ******* (***) ***
****** ***** ****** ***** ************ ******* *********** **** **. *-*/*&* *******, (******* ******** ****) ******, ******* ***** *.*. **. **, ***-******, ****-*********, *********, ******* ******, ***** (***) ***
****** ***** ***** ** *** ***** ************** **., ***. ****** ***** *********** **. ** ********* *** **., ******* *******, ****** ****,****** ******, - *****, ****** (***) ***
****** ****** ****** ****** *************** ** *** ****, *** *********** ** ********** **, **********, *** **** (**) *****-****, ****** ****** (***) ***
****** ***** ****** ***** ****** ************ ******* *********** ****-*, **. **. ***, *** & ***, ******* *******, ********* ******, *******-**********, ********* ******, ***** (***) ***
****** ****** ******** ***** *************** ******* *********** **** **. * ** **, *******, **** ******* ******, *******-***** *******, **. *-*, ****** ******, *********, ******* ******, ***** (***) ***
****** ***** **** *** ***** ************, ***. *********** ***\***\*** ****** ******, *********, *** ****** (**) *****, ****** ****** (***) ***
****** ******* ******* *************** ******* *********** ****** **. **,** *** **, *******, ****** *****, **********, ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.